Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

NCT02194634 is registered in ClinicalTrials.gov with Chengdu Kanghong Biotech Co., Ltd. as lead sponsor.

NCT NCT02194634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02194634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
Lead sponsor
Chengdu Kanghong Biotech Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2014
Completion date
September 30, 2017
Enrollment
248 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema